AccessibilityHelp
Quantum BioPharma Ltd. logo

Quantum BioPharma Ltd.(NASDAQ) QNTM

Market Cap$18.12MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-100%
5 Year-98%
1 Year-84%
1 Month-42%
$2.26
-0.44%
-0.01Today
After hours$2.25-$0.01 (-0.44%)
Quantum BioPharma Ltd. last closing stock price
MetricPriceDate
Last closeUSD 2.242026-10-23
Quantum BioPharma Ltd. stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-9.31%USD 2.472026-10-16
1 month-42.27%USD 3.882026-09-23
3 month-25.08%USD 2.992026-07-24
Year to date-69.32%USD 7.302025-12-31
1 year-84.49%USD 14.442025-10-23
3 year-96.75%USD 68.902023-10-24
5 year-97.59%USD 92.952021-10-22
Since inception-99.79%USD 1,089.632018-06-11

Quantum BioPharma Ltd. Financials at a Glance

Market Cap

$18.12MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$24.89M

EPS (TTM)

-$5.69

P/E Ratio

-0.39

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Price

$2.26

Volume

42,707

Open

$2.26

Previous Close

$2.24

Daily Range

$2.24 - $2.37

52-Week Range

$2.07 - $14.85

Estimated Earnings Date

Nov 6, 2026

QNTM News

Smoldering Fire Cannabis Bud Marijuana Weed Pot Canada US Getty

Canna-Bust! These 6 Pot Stocks Lost at Least 25% in July

Sean WilliamsAug 6, 2019
Cash Money Bills On Fire Invest Loss Bankrupt Getty

The 6 Worst Pot Stocks in the First Half of 2019

Sean WilliamsJul 2, 2019
Marijuana Plant Cannabis Pot Weed Legalization Getty

These 5 Pot Stocks Lost at Least 15% in the First Quarter

Sean WilliamsApr 9, 2019
Stock Trader Losing Money Investment Growth Value Getty

These 5 Pot Stocks Lost 16% (or More) in February

Sean WilliamsMar 5, 2019

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Quantum BioPharma Ltd.

Quantum BioPharma Ltd. is a biopharmaceutical firm based in Toronto, Canada, focused on developing innovative solutions for complex neurodegenerative, inflammatory, and metabolic conditions. The company is advancing a diverse pipeline of drug candidates, including treatments for alcohol use disorder, with its flagship asset, Lucid-MS, currently in Phase 2 clinical trials.

Products and Services
  • Lucid-MS, a proprietary drug candidate for multiple sclerosis
  • Therapeutic solutions targeting alcohol addiction
  • Strategic investments in collateralized loans
Growth Outlook
  • Lucid-MS shows promising preclinical data for myelin degradation reversal
  • Expansion into alcohol addiction treatment markets is underway
  • Strategic investments provide additional revenue streams
Financial Highlights
  • Recent quarterly net income of -$3.17 million reflects ongoing R&D investments
  • Cash and short-term investments total approximately $9.73 million
  • Current ratio of 1.20 indicates adequate short-term financial health
Quantum BioPharma Ltd. is positioned in the biotechnology sector, addressing significant unmet medical needs. The company's focus on neurodegenerative diseases and alcohol use disorder aligns with growing healthcare demands. The promising data from Lucid-MS and the strategic investment portfolio may enhance its market presence and financial stability. Recent financial metrics indicate a commitment to research and development, which is crucial for long-term growth. Investors may find Quantum BioPharma's innovative approach and strategic direction noteworthy as the company navigates the complexities of the biopharmaceutical landscape.
AI Generated • Oct 22, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

7

CEO

Zeeshan Saeed

Website

www.quantumbiopharma.com

Headquarters

Toronto, ON M5C 2V9, CA

QNTM Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-413.07%

Return on Capital

-174.19%

Return on Assets

-173.14%

Earnings Yield

-2.56%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$18.12MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

8.09M

Volume

42.71K

Avg. Volume

205.95K

Financials (TTM)

Gross Profit

-$250.78K

Operating Income

-$1.91M

EBITDA

-$23.66M

Operating Cash Flow

-$5.42M

Capital Expenditure

-$6.00

Free Cash Flow

-$5.42M

Cash & ST Invst.

$9.73M

Total Debt

$962.16K

Quantum BioPharma Ltd. Performance Analysis

Quantum BioPharma Ltd. annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
Quantum BioPharma Ltd. sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30N/A
Q42025-12-31N/A
Q12026-03-31N/A
Q22026-06-30N/A
Quantum BioPharma Ltd. annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.61-39.6%
20232023-12-31USD -0.46-24.4%
20242024-12-31USD -12.492612.8%
20252025-12-31USD -7.97-36.2%
Quantum BioPharma Ltd. sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3054.2%
Q42025-12-3143.6%
Q12026-03-31-277.2%
Q22026-06-3083.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$125.11K

N/A

Gross Margin

0.00%

N/A

Market Cap

$18.12MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.07M

N/A

Employees

17

N/A

Net Income

-$3.17M

+65.7%

EBITDA

-$2.12M

+77.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$9.73M

+536.9%

Total Debt

$962.16K

-57.5%

Accounts Receivable

$107.50K

-96.7%

Inventory

$52.95K

-31.1%

Long Term Debt

$0.00

N/A

Short Term Debt

$962.16K

-57.5%

Return on Assets

-1.73%

N/A

Return on Invested Capital

-31.43%

N/A

Free Cash Flow

-$1.74M

+10.5%

Operating Cash Flow

-$1.74M

+10.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EVAXEvaxion Biotech A/S
$3.76+1.35%
RMTIRockwell Medical, Inc.
$6.94-1.70%
RVPHReviva Pharmaceuticals Holdings, Inc.
$0.45-5.68%
CELUCelularity Inc.
$0.98-6.89%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$147.49+1.89%
TAT&T
$20.93-7.96%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$83.56+1.77%
NUNu Holdings
$15.16+2.92%

Questions About QNTM

What is the current price of Quantum BioPharma Ltd.?

Quantum BioPharma Ltd. is trading at $2.24 per share.

What is the 52-week range for Quantum BioPharma Ltd.?

Over the past 52 weeks, Quantum BioPharma Ltd. has traded between $2.07 and $14.85.

How much debt does Quantum BioPharma Ltd. have?

As of the most recent reporting period, Quantum BioPharma Ltd. reported total debt of $963.31K.

How much cash does Quantum BioPharma Ltd. have on hand?

Quantum BioPharma Ltd. reported $3.65M in cash and cash equivalents in its most recent financial results.

What is Quantum BioPharma Ltd.’s dividend yield?

Quantum BioPharma Ltd. does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services